NeuroMetrix names new consumer GM | Personnel Moves
Palomar Medical Technologies Inc.
Cynosure inks $10M settlement with Tria Beauty
Cynosure shares fall on slide to Q3 red
Cynosure closes $287 Palomar Medical buyout
Cynosure’s Q1 earnings miss expectations
Cynosure snaps up Palomar Medical Technologies for $294 million
Aesthetic laser maker Cynosure (NSDQ:CYNO) snapped up another competitor, acquiring Palomar Medical (NSDQ:PMTI) for $294 million in cash and stock.
Palomar Medical gains on swing to Q4 black
Palomar Medical (NSDQ:PMTI) gained on Wall Street today after a swing to 4th-quarter profits bested Wall Street’s earnings expectations by 1 thin dime.
KCI in stealthy buyout of MoMelan | Wall Street Beat
Kinetic Concepts executed an under-the-radar buyout of skin graft developer MoMelan Technologies, according to Xconomy.com, citing an anonymous investor in MoMelan.
The acquisition, to which the investor declined to assign a value, is "a good outcome for everybody – founders, investors, employees,” according to the unnamed source.
Palomar’s non-royalty revenues jump 300% in Q3
Palomar Medical (NSDQ:PMTI) made big strides in its professional product revenues during the 3 months ended Sept. 30, 2012, but stayed in the red for the quarter.
The Burlington, Mass.-based aesthetic medical device maker reported a net loss of $4.7 million, or 25¢ per share, on sales of $18.5 million for the 3 months ended Sept. 30.
By the numbers: The aesthetic medical device market picks up during the 2nd quarter
The market for aesthetic medical devices gained some ground during the 2nd quarter, a MassDevice.com analysis shows, although healthy sales growth didn’t necessarily translate into healthy bottom lines for all comers.
